Hepatic steatosis and advanced fibrosis are independent predictors of mortality in acute myocardial infarction without standard modifiable risk factors
Nicholas Chew, Gemma A. Figtree, Gwyneth Kong, Steve Vernon, Mark Muthiah, Cheng Han Ng, Mark Y. Chan, Poay Huan Loh
Abstract
Gemma A. Figtree receives funding from the National Health and Medical Research Council (Australia), New South Wales Office of Health and Medical Research, and Heart Research Australia. She reports personal consulting fees from CSL, Janssen, Amgen and Boehringer Ingelheim and grants from Abbott Diagnostic outside the submitted work. In addition, she has a patent Biomarkers and Oxidative Stress awarded USA May 2017 (US9638699B2) issued to Northern Sydney Local Health District. Mark Y. Chan has received speaker's fees and research grants from Astra Zeneca, Abbott Technologies and Boston Scientific. All other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. The peer review history for this article is available at https://publons.com/publon/10.1111/dom.14820. The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.